---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-077546"
form_type: "8-K"
ticker: "NXTC"
cik: "0001661059"
company_name: "NextCure, Inc."
filed_at: "2026-06-25T12:01:26+00:00"
generated_at: "2026-06-25T12:05:25.718646+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# NextCure shareholders elect directors, approve amended equity plan with 80,000 additional shares

## Summary
- Anne Borgman, M.D. and John G. Houston, Ph.D. reelected as Class I directors for 3-year terms.
- Shareholders approved amendment and restatement of 2019 Omnibus Incentive Plan, increasing authorized shares by 80,000.
- Ratification of Ernst & Young LLP as independent auditor for fiscal 2026 passed with 2,774,832 votes for.
- Advisory vote on executive compensation passed with 2,109,269 votes for.

## SEC filing metadata
- accession: 0001104659-26-077546
- form_type: 8-K
- ticker: NXTC
- cik: 0001661059
- company_name: NextCure, Inc.
- filed_at: 2026-06-25T12:01:26+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661059/000110465926077546/0001104659-26-077546-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661059/000110465926077546/nxtc-20260618x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-077546
- JSON: https://secwatch.observer/filing/0001104659-26-077546.json
- Plain text: https://secwatch.observer/filing/0001104659-26-077546.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.